Capital Advisory Group Advisory Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-54	Closed	-$10K	–	584
2021 Q2	$10K	Hold	54	–	–	﹤0.01%	401
2021 Q1	$8K	Hold	54	–	–	﹤0.01%	417
2020 Q4	$8K	Hold	54	–	–	﹤0.01%	397
2020 Q3	$6K	Hold	54	–	–	﹤0.01%	374
2020 Q2	$6K	Hold	54	–	–	﹤0.01%	366
2020 Q1	$5K	Buy	+54	New	+$5.3K	0.01%	315
2019 Q4	–	Sell	-54	Closed	-$5K	–	456
2019 Q3	$5K	Hold	54	–	–	﹤0.01%	349
2019 Q2	$7K	Buy	+54	New	+$6.96K	﹤0.01%	323

Other funds holding ALXN

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return